BC
Bicara Therapeutics Inc. Common Stock (BCAX)
NASDAQ·Healthcare·Biotechnology
$22.92
-0.71%
Mkt Cap $1.56B
Analyst Ratings
Buy
6
Hold
6
Sell
0
Price Target (10 analysts)
$32.33
Range $18.00 – $42.00
Implied Upside
+41.1%
Consensus $32.33 vs current $22.92